Construction and Validation of a Novel Pyroptosis-Related Gene Signature to Predict the Prognosis of Uveal Melanoma
Uveal melanoma is the most common primary intraocular tumor with a poor prognosis. Currently, treatment for UVM is limited, and the development of drug resistance and tumor recurrence are common. Therefore, it is important to identify new prognostic biomarkers of UVM and explore their role in the tu...
Guardado en:
Autores principales: | Yuan Cao, Jiaheng Xie, Liang Chen, Yiming Hu, Leili Zhai, Jin Yuan, Long Suo, Yaming Shen, Rong Ye, Jiajun Li, Zixuan Gong, Yunfan Dong, Wei Bao, Huan Li, Ming Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c3d992369f254ff8828b3c86658d396a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Posterior uveal melanoma in adolescents and children: current perspectives
por: Fry MV, et al.
Publicado: (2018) -
Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Rino S. Seedor, et al.
Publicado: (2021) -
Blood Biomarkers of Uveal Melanoma: Current Perspectives
por: Bande Rodríguez MF, et al.
Publicado: (2020) -
AMBRA1 attenuates the proliferation of uveal melanoma cells
por: Zhao Binbin, et al.
Publicado: (2021) -
The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Jan Pals, et al.
Publicado: (2021)